Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis

NCT04871945 · clinicaltrials.gov ↗

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Vaccine Reaction
Hemolysis
End-stage Renal Disease

Interventions

DIAGNOSTIC_TEST: Elecsys Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany), 2) ACCESS SARS-CoV-2 IgG II (Beckman Coulter, Inc. USA)

Sponsor

Hanyang University Seoul Hospital

Collaborators

[object Object]